VOR Vor Biopharma Inc

1.555

-0.055 (-3.42%)

25 May 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type
Vor Biopharma Inc	NASDAQ:VOR	NASDAQ	Common Stock

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-0.055	-3.42%	1.555	1.57	1.74	1.63	1.55	1.63	329,956	01:00:00

Vor Bio to Participate in the Goldman Sachs Healthcare Conference

05/06/2023 1:00pm

GlobeNewswire Inc.

Vor Biopharma (NASDAQ:VOR)
Historical Stock Chart

From May 2023 to May 2024

Click Here for more Vor Biopharma Charts.

Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will present and host in-person 1x1 investor meetings at the Goldman Sachs 44th Annual Global Healthcare Conference.

Goldman Sachs 44th Annual Global Healthcare ConferenceFireside Chat: Monday, June 12, 2023 at 8:00am PTLocation: Waldorf Astoria Monarch Beach Resort & Club, Dana Point, CA

A live webcast and archived replay of the fireside chat will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/

About Vor BioVor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contact:

Media & InvestorsSarah Spencer +1 857-242-6076sspencer@vorbio.com